• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment.

作者信息

Brugnatelli Viola, Turco Fabio, Freo Ulderico, Zanette Gastone

机构信息

Department of Neuroscience, University of Padua, Padua, Italy.

Molecular Biology and Biochemistry Lab, Department of Neurogastroentherology, University of Naples Federico II, Naples, Italy.

出版信息

Front Neurosci. 2020 Apr 21;14:371. doi: 10.3389/fnins.2020.00371. eCollection 2020.

DOI:10.3389/fnins.2020.00371
PMID:32372912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7186328/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a6f/7186328/8c60f5322fe9/fnins-14-00371-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a6f/7186328/8c60f5322fe9/fnins-14-00371-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a6f/7186328/8c60f5322fe9/fnins-14-00371-g0001.jpg

相似文献

1
Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment.肠易激综合征：将内源性大麻素系统作为一线治疗手段进行调控
Front Neurosci. 2020 Apr 21;14:371. doi: 10.3389/fnins.2020.00371. eCollection 2020.
2
Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.大麻素受体在非小细胞肺癌中的表达。四氢大麻酚和大麻二酚抑制体外细胞增殖和上皮-间充质转化的效果。
PLoS One. 2020 Feb 12;15(2):e0228909. doi: 10.1371/journal.pone.0228909. eCollection 2020.
3
Endocannabinoid system in irritable bowel syndrome and cannabis as a therapy.肠易激综合征中的内源性大麻素系统和大麻作为一种疗法。
Complement Ther Med. 2020 Jan;48:102242. doi: 10.1016/j.ctim.2019.102242. Epub 2019 Nov 13.
4
New Insights of Uterine Leiomyoma Pathogenesis: Endocannabinoid System.子宫平滑肌瘤发病机制的新见解：内源性大麻素系统
Med Sci Monit Basic Res. 2019 Mar 7;25:76-87. doi: 10.12659/MSMBR.914019.
5
Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.大麻二酚和棕榈酰乙醇胺对急性发炎的人体结肠具有抗炎作用。
Clin Sci (Lond). 2017 Oct 25;131(21):2611-2626. doi: 10.1042/CS20171288. Print 2017 Nov 1.
6
Activation of cannabinoid 2 receptor relieves colonic hypermotility in a rat model of irritable bowel syndrome.大麻素 2 型受体的激活可缓解肠易激综合征大鼠模型中的结肠高运动性。
Neurogastroenterol Motil. 2019 Jun;31(6):e13555. doi: 10.1111/nmo.13555. Epub 2019 Feb 21.
7
Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.棕榈酸乙醇酰胺和大麻二酚可预防人肠道炎症诱导的通透性增加：一项随机、安慰剂对照、双盲对照临床试验。
Inflamm Bowel Dis. 2019 May 4;25(6):1006-1018. doi: 10.1093/ibd/izz017.
8
P2Y1, P2Y2, and TRPV1 Receptors Are Increased in Diarrhea-Predominant Irritable Bowel Syndrome and P2Y2 Correlates with Abdominal Pain.P2Y1、P2Y2和TRPV1受体在腹泻型肠易激综合征中表达增加，且P2Y2与腹痛相关。
Dig Dis Sci. 2016 Oct;61(10):2878-2886. doi: 10.1007/s10620-016-4211-5. Epub 2016 Jun 1.
9
Cannabidiol and the Remainder of the Plant Extract Modulate the Effects of Δ9-Tetrahydrocannabinol on Fear Memory Reconsolidation.大麻二酚与植物提取物的其余部分调节Δ9-四氢大麻酚对恐惧记忆再巩固的影响。
Front Behav Neurosci. 2019 Aug 1;13:174. doi: 10.3389/fnbeh.2019.00174. eCollection 2019.
10
The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome.内源性大麻素系统在肠易激综合征病理生理学及治疗中的作用
Neurogastroenterol Motil. 2008 Aug;20(8):857-68. doi: 10.1111/j.1365-2982.2008.01175.x.

引用本文的文献

1
FMT and TCM to treat diarrhoeal irritable bowel syndrome with induced spleen deficiency syndrome- microbiomic and metabolomic insights.FMT 和 TCM 治疗脾虚型腹泻型肠易激综合征的微生物组学和代谢组学研究。
BMC Microbiol. 2024 Oct 26;24(1):433. doi: 10.1186/s12866-024-03592-y.
2
Neuro-Gastro-Cannabinology: A Novel Paradigm for Regulating Mood and Digestive Health.神经胃肠大麻素学：调节情绪与消化健康的新范式
Med Cannabis Cannabinoids. 2023 Oct 27;6(1):130-137. doi: 10.1159/000534007. eCollection 2023 Jan-Dec.
3
Effects of Cannabidiol Chewing Gum on Perceived Pain and Well-Being of Irritable Bowel Syndrome Patients: A Placebo-Controlled Crossover Exploratory Intervention Study with Symptom-Driven Dosing.

本文引用的文献

1
Endocannabinoid system in irritable bowel syndrome and cannabis as a therapy.肠易激综合征中的内源性大麻素系统和大麻作为一种疗法。
Complement Ther Med. 2020 Jan;48:102242. doi: 10.1016/j.ctim.2019.102242. Epub 2019 Nov 13.
2
Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes.重新审视临床内源性大麻素缺乏症：当前研究支持偏头痛、纤维肌痛、肠易激综合征及其他难治性综合征中的该理论。
Cannabis Cannabinoid Res. 2016 Jul 1;1(1):154-165. doi: 10.1089/can.2016.0009. eCollection 2016.
3
TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endocannabinoids and Nociceptive Signalling.
CBD 口香糖对肠易激综合征患者疼痛和舒适度的影响：一项基于症状驱动剂量的安慰剂对照交叉探索性干预研究
Cannabis Cannabinoid Res. 2022 Aug;7(4):436-444. doi: 10.1089/can.2020.0087. Epub 2021 Feb 11.
4
Cannabinoid Receptors Overexpression in a Rat Model of Irritable Bowel Syndrome (IBS) after Treatment with a Ketogenic Diet.大麻素受体在生酮饮食治疗后肠易激综合征（IBS）大鼠模型中的过度表达。
Int J Mol Sci. 2021 Mar 12;22(6):2880. doi: 10.3390/ijms22062880.
5
Editorial: Application of Plant Secondary Metabolites to Pain Neuromodulation.社论：植物次生代谢产物在疼痛神经调节中的应用
Front Pharmacol. 2021 Jan 14;11:623399. doi: 10.3389/fphar.2020.623399. eCollection 2020.
TRP 通道作为内源性配体的新型靶点：聚焦内源性大麻素和伤害性信号。
Curr Neuropharmacol. 2018 Jan 30;16(2):137-150. doi: 10.2174/1570159X15666170424120802.
4
Endocannabinoid system acts as a regulator of immune homeostasis in the gut.内源性大麻素系统作为肠道免疫稳态的调节因子。
Proc Natl Acad Sci U S A. 2017 May 9;114(19):5005-5010. doi: 10.1073/pnas.1612177114. Epub 2017 Apr 24.
5
Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but Not in the Population.情绪和焦虑障碍先于功能性胃肠疾病在患者中出现，但在人群中并非如此。
Clin Gastroenterol Hepatol. 2017 Jul;15(7):1014-1020.e4. doi: 10.1016/j.cgh.2016.12.032. Epub 2017 Jan 10.
6
Endocannabinoids in the gastrointestinal tract.胃肠道中的内源性大麻素。
Am J Physiol Gastrointest Liver Physiol. 2016 Oct 1;311(4):G655-G666. doi: 10.1152/ajpgi.00294.2015. Epub 2016 Aug 18.
7
Endocannabinoids in the Gut.肠道中的内源性大麻素
Cannabis Cannabinoid Res. 2016 Feb;1(1):67-77. doi: 10.1089/can.2016.0001. Epub 2016 Feb 24.
8
The Role of the Endocannabinoid System in the Brain-Gut Axis.内源性大麻素系统在脑-肠轴中的作用。
Gastroenterology. 2016 Aug;151(2):252-66. doi: 10.1053/j.gastro.2016.04.015. Epub 2016 Apr 29.
9
Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.组胺受体 H1 介导的 TRPV1 敏化参与肠易激综合征患者内脏敏感性和症状的发生。
Gastroenterology. 2016 Apr;150(4):875-87.e9. doi: 10.1053/j.gastro.2015.12.034. Epub 2016 Jan 2.
10
Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol.Δ9-四氢大麻酚长期处理对小鼠饮食诱导肥胖的体重及肠道微生物群的预防作用
PLoS One. 2015 Dec 3;10(12):e0144270. doi: 10.1371/journal.pone.0144270. eCollection 2015.